R. Matthew Walsh, MD

Appointed
1991

Education & Fellowships

Fellowship - Cleveland Clinic
General Surgery
Cleveland, OH
1991

Fellowship - Massachusetts General Hospital
Surgical Endoscopy
Boston, MA
1990

Residency - Loyola University Medical Center
General Surgery
Maywood, IL
1990

Internship - Loyola University Medical Center
Surgical Internship
Maywood, IL United States
1986

Medical Education - Medical College of Wisconsin
MD
Milwaukee, WI
1985

Undergraduate - Creighton University
Biology
Omaha, NE
1981

Certifications

• Surgery

Specialty Interests

Biliary and pancreatic surgery, gastrointestinal surgery, general surgery, hepatobiliary and pancreatic surgery, hepatobiliary surgery, laparoscopy, surgical endoscopy, surgical oncology, robotic surgery

Awards & Honors

• Dean’s List - 1978-1981
• Creighton University, Outstanding Scholastic Achievement Award 1980
• Summa Cum Laude - 1981
• John F. Keeley Surgical Scholarship - 1989
  • National Cancer Institute, Washington DC
  • University of Melbourne, Victoria, Australia, Research Project: “Immunotherapeutic Approaches, For Colon Cancer: The Use of Recombinant Antigen, Presentation and Immunoconjugates”
  • 1997 Faculty Teaching Award, The Ohio State University College of Medicine - 1997
  • Teacher of the Year , Cleveland Clinic Housestaff- 2000,
  • The Distinguished Educator Award, The Ohio State University - 2001
  • Associate Examiner, American Board of Surgery - 1999, 2002
  • Harvard-Macy Institute Program for Physician Educators - 2002
  • Teacher of the Year - 2003, 2004,
  • Department of General Surgery, Cleveland Clinic Housestaff - 2006, 2008
  • Examiner, American Board of Surgery - 2006, 2007, 2008, 2009
  • Kaiser-Permanente Excellence in Teaching Award, Case Western Reserve University College of Medicine - 2008,
  • Rich Family Distinguished Chair of Digestive Diseases- 2009
  • Service Excellence Award, health Network Foundation - 2010
  • The Rich Family Distinguished Chair in Digestive Diseases 2009

See publications for R. Matthew Walsh, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 10/18/2024, Dr. Walsh has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.